Capone Mark Christopher
- SEC CIK
- 0001352413
In the past year, 1 open-market purchase filing worth $99.3K and no sales.
Current role at each company
- MLAB Mesa Laboratories IncDirectoras of Sep 11, 2026
- SERA Sera Prognostics, Inc.Directoras of Jul 14, 2026
- DMTK DermTech, Inc.Directoras of Jun 5, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $99.3K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$99.3K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Capone Mark Christopher as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MLAB Mesa Laboratories Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2026 (view filing) | Mar 10 | Same day | Capone Mark ChristopherDirector | PPurchase | +1.30K | $76.35 | +$99.3K | +61.1%3.43K after |